AFP and hepatocellular carcinoma: Although our current study supports that the combination of AFP and CA19-9 can greatly improve the prediction of post-hepatectomy prognosis for HCC patients, our results should be interpreted carefully due to several limitations such as the lack of additional serum markers and short follow-up of the enrolled patients.